- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02126943
OPsumit brugerregister (OPUS)
28. marts 2025 opdateret af: Actelion
USA-baserede, observationelle, lægemiddelregister af Opsumit® (Macitentan) Nye brugere i klinisk praksis
Prospektivt observationelt lægemiddelregister udviklet til at karakterisere sikkerhedsprofilen (herunder primært potentielle alvorlige leverrisici) og til at beskrive kliniske karakteristika og resultater for patienter, der er nyligt behandlet med Opsumit efter markedsføring.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
2686
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Alabama
-
Mobile, Alabama, Forenede Stater, 36604
- Investigator Site
-
-
Arizona
-
Phoenix, Arizona, Forenede Stater, 85032
- Investigator Site
-
Phoenix, Arizona, Forenede Stater, 85006
- Investigator Site
-
Phoenix, Arizona, Forenede Stater, 85054
- Investigator Site
-
-
California
-
Fullerton, California, Forenede Stater, 92835
- Investigator Site
-
La Jolla, California, Forenede Stater, 92093
- Investigator Site
-
Loma Linda, California, Forenede Stater, 92354
- Investigator Site
-
Los Angeles, California, Forenede Stater, 90033
- Investigator Site
-
Los Angeles, California, Forenede Stater, 90095-1690
- Investigator Site
-
Los Angeles, California, Forenede Stater, 90211
- Investigator Site
-
Moreno Valley, California, Forenede Stater, 92553
- Investigator Site
-
San Juan Capistrano, California, Forenede Stater, 92675
- Investigator Site
-
Santa Barbara, California, Forenede Stater, 93105
- Investigator Site
-
Stanford, California, Forenede Stater, 94305
- Investigator Site
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80045
- Investigator Site
-
Denver, Colorado, Forenede Stater, 80206
- Investigator Site
-
Greeley, Colorado, Forenede Stater, 80631
- Investigator Site
-
Wheat Ridge, Colorado, Forenede Stater, 80033
- Investigator Site
-
-
Connecticut
-
New Haven, Connecticut, Forenede Stater, 06515
- Investigator Site
-
-
Delaware
-
Newark, Delaware, Forenede Stater, 19718
- Investigator Site
-
-
District of Columbia
-
Washington, District of Columbia, Forenede Stater, 20007
- Investigator Site
-
-
Florida
-
Brandon, Florida, Forenede Stater, 33511
- Investigator Site
-
Celebration, Florida, Forenede Stater, 34747
- Investigator Site
-
Clermont, Florida, Forenede Stater, 34711
- Investigator Site
-
Fort Lauderdale, Florida, Forenede Stater, 33316
- Investigator Site
-
Gainesville, Florida, Forenede Stater, 32610
- Investigator Site
-
Hudson, Florida, Forenede Stater, 34667
- Investigator Site
-
Jacksonville, Florida, Forenede Stater, 32207
- Investigator Site
-
Jacksonville, Florida, Forenede Stater, 32209
- Investigator Site
-
Kissimmee, Florida, Forenede Stater, 34741
- Investigator Site
-
Leesburg, Florida, Forenede Stater, 34748
- Investigator Site
-
Melbourne, Florida, Forenede Stater, 32901
- Investigator Site
-
Miami, Florida, Forenede Stater, 33136
- Investigator Site
-
Miami, Florida, Forenede Stater, 33125
- Investigator Site
-
Miami Beach, Florida, Forenede Stater, 33140
- Investigator Site
-
Orlando, Florida, Forenede Stater, 32803
- Investigator Site
-
Pensacola, Florida, Forenede Stater, 32504
- Investigator Site
-
Saint Petersburg, Florida, Forenede Stater, 33701
- Investigator Site
-
Saint Petersburg, Florida, Forenede Stater, 33704
- Investigator Site
-
Saint Petersburg, Florida, Forenede Stater, 33707
- Investigator Site
-
Sebring, Florida, Forenede Stater, 33870
- Investigator Site
-
South Miami, Florida, Forenede Stater, 33143
- Investigator Site
-
Tampa, Florida, Forenede Stater, 33606
- Investigator Site
-
Weston, Florida, Forenede Stater, 33331
- Investigator Site
-
Zephyrhills, Florida, Forenede Stater, 33542
- Investigator Site
-
-
Georgia
-
Marietta, Georgia, Forenede Stater, 30060
- Investigator Site
-
-
Hawaii
-
Honolulu, Hawaii, Forenede Stater, 96813
- Investigator Site
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60611
- Investigator Site
-
Oak Brook, Illinois, Forenede Stater, 60181
- Investigator Site
-
Oak Brook, Illinois, Forenede Stater, 60523
- Investigator Site
-
-
Indiana
-
Carmel, Indiana, Forenede Stater, 46032
- Investigator Site
-
Fort Wayne, Indiana, Forenede Stater, 46804
- Investigator Site
-
Greenwood, Indiana, Forenede Stater, 46143
- Investigator Site
-
Indianapolis, Indiana, Forenede Stater, 46260
- Investigator Site
-
-
Iowa
-
Clive, Iowa, Forenede Stater, 50325
- Investigator Site
-
Iowa City, Iowa, Forenede Stater, 52242
- Investigator Site
-
-
Kansas
-
Kansas City, Kansas, Forenede Stater, 66160
- Investigator Site
-
-
Kentucky
-
Lexington, Kentucky, Forenede Stater, 40536
- Investigator Site
-
Louisville, Kentucky, Forenede Stater, 40202
- Investigator Site
-
-
Louisiana
-
New Orleans, Louisiana, Forenede Stater, 70112
- Investigator Site
-
New Orleans, Louisiana, Forenede Stater, 70121
- Investigator Site
-
Shreveport, Louisiana, Forenede Stater, 71105
- Investigator Site
-
Shreveport, Louisiana, Forenede Stater, 71130
- Investigator Site
-
-
Maine
-
South Portland, Maine, Forenede Stater, 04106
- Investigator Site
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21201
- Investigator Site
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02114
- Investigator Site
-
Boston, Massachusetts, Forenede Stater, 02111
- Investigator Site
-
Boston, Massachusetts, Forenede Stater, 02118
- Investigator Site
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48109-0273
- Investigator Site
-
Detroit, Michigan, Forenede Stater, 48202
- Investigator Site
-
Lansing, Michigan, Forenede Stater, 48910
- Investigator Site
-
Troy, Michigan, Forenede Stater, 48085
- Investigator Site
-
-
Minnesota
-
Minneapolis, Minnesota, Forenede Stater, 55407-3799
- Investigator Site
-
Rochester, Minnesota, Forenede Stater, 55905
- Investigator Site
-
-
Missouri
-
Saint Louis, Missouri, Forenede Stater, 63104
- Investigator Site
-
Saint Louis, Missouri, Forenede Stater, 63141
- Investigator Site
-
-
Nebraska
-
Lincoln, Nebraska, Forenede Stater, 68506
- Investigator Site
-
Omaha, Nebraska, Forenede Stater, 68198-5990
- Investigator Site
-
-
Nevada
-
Reno, Nevada, Forenede Stater, 89503
- Investigator Site
-
-
New Jersey
-
Cherry Hill, New Jersey, Forenede Stater, 08034
- Investigator Site
-
Newark, New Jersey, Forenede Stater, 07112
- Investigator Site
-
Union, New Jersey, Forenede Stater, 07002
- Investigator Site
-
-
New Mexico
-
Albuquerque, New Mexico, Forenede Stater, 87106
- Investigator Site
-
-
New York
-
Albany, New York, Forenede Stater, 12208
- Investigator Site
-
Bronx, New York, Forenede Stater, 10467
- Investigator Site
-
Brooklyn, New York, Forenede Stater, 11215
- Investigator Site
-
Fayetteville, New York, Forenede Stater, 13066
- Investigator Site
-
Hauppauge, New York, Forenede Stater, 11788
- Investigator Site
-
Mineola, New York, Forenede Stater, 11501
- Investigator Site
-
New Hyde Park, New York, Forenede Stater, 11040
- Investigator Site
-
New York, New York, Forenede Stater, 10016
- Investigator Site
-
New York, New York, Forenede Stater, 10029
- Investigator Site
-
-
North Carolina
-
Chapel Hill, North Carolina, Forenede Stater, 27599
- Investigator Site
-
Durham, North Carolina, Forenede Stater, 27710
- Investigator Site
-
Greensboro, North Carolina, Forenede Stater, 27401
- Investigator Site
-
Pinehurst, North Carolina, Forenede Stater, 28374
- Investigator Site
-
-
Ohio
-
Canton, Ohio, Forenede Stater, 44708
- Investigator Site
-
Cincinnati, Ohio, Forenede Stater, 43130
- Investigator Site
-
Cincinnati, Ohio, Forenede Stater, 45219
- Investigator Site
-
Cincinnati, Ohio, Forenede Stater, 45242-5223
- Investigator Site
-
Cincinnati, Ohio, Forenede Stater, 45267-2564
- Investigator Site
-
Columbus, Ohio, Forenede Stater, 43210
- Investigator Site
-
Columbus, Ohio, Forenede Stater, 43213
- Investigator Site
-
Dayton, Ohio, Forenede Stater, 45459
- Investigator Site
-
Lima, Ohio, Forenede Stater, 45801
- Investigator Site
-
Middleburg Heights, Ohio, Forenede Stater, 44130
- Investigator Site
-
Toledo, Ohio, Forenede Stater, 43614
- Investigator Site
-
Wooster, Ohio, Forenede Stater, 44691
- Investigator Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73112
- Investigator Site
-
-
Oregon
-
Portland, Oregon, Forenede Stater, 97210
- Investigator Site
-
Portland, Oregon, Forenede Stater, 97225
- Investigator Site
-
Portland, Oregon, Forenede Stater, 97239-3098
- Investigator Site
-
-
Pennsylvania
-
Abington, Pennsylvania, Forenede Stater, 19001
- Investigator Site
-
Doylestown, Pennsylvania, Forenede Stater, 18907
- Investigator Site
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Investigator Site
-
Philadelphia, Pennsylvania, Forenede Stater, 19107
- Investigator Site
-
Philadelphia, Pennsylvania, Forenede Stater, 19140
- Investigator Site
-
Pittsburgh, Pennsylvania, Forenede Stater, 15213
- Investigator Site
-
Wynnewood, Pennsylvania, Forenede Stater, 19096
- Investigator Site
-
York, Pennsylvania, Forenede Stater, 17402
- Investigator Site
-
-
South Carolina
-
Anderson, South Carolina, Forenede Stater, 29621
- Investigator Site
-
Charleston, South Carolina, Forenede Stater, 29425
- Investigator Site
-
Columbia, South Carolina, Forenede Stater, 29204
- Investigator Site
-
Rock Hill, South Carolina, Forenede Stater, 29732
- Investigator Site
-
-
South Dakota
-
Sioux Falls, South Dakota, Forenede Stater, 57108
- Investigator Site
-
-
Tennessee
-
Chattanooga, Tennessee, Forenede Stater, 37404
- Investigator Site
-
Memphis, Tennessee, Forenede Stater, 38157
- Investigator Site
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75390-8550
- Investigator Site
-
Houston, Texas, Forenede Stater, 77030
- Investigator Site
-
Plano, Texas, Forenede Stater, 75093
- Investigator Site
-
San Antonio, Texas, Forenede Stater, 78229
- Investigator Site
-
Sherman, Texas, Forenede Stater, 75092
- Investigator Site
-
Temple, Texas, Forenede Stater, 76508-0001
- Investigator Site
-
Weslaco, Texas, Forenede Stater, 78596
- Investigator Site
-
-
Virginia
-
Charlottesville, Virginia, Forenede Stater, 22908
- Investigator Site
-
Falls Church, Virginia, Forenede Stater, 22042
- Investigator Site
-
Norfolk, Virginia, Forenede Stater, 23507
- Investigator Site
-
Richmond, Virginia, Forenede Stater, 23298-0050
- Investigator Site
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98195
- Investigator Site
-
Spokane, Washington, Forenede Stater, 99204
- Investigator Site
-
Tacoma, Washington, Forenede Stater, 98405
- Investigator Site
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53792
- Investigator Site
-
Milwaukee, Wisconsin, Forenede Stater, 53215
- Investigator Site
-
Milwaukee, Wisconsin, Forenede Stater, 53226
- Investigator Site
-
-
-
-
-
Guaynabo, Puerto Rico, 00968
- Investigator Site
-
Ponce, Puerto Rico, 00716
- Investigator Site
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Patienter nybehandlet med Opsumit
Beskrivelse
Inklusionskriterier:
Patienter, der er nybehandlet med Opsumit, defineret som en ny bruger af terapi, påbegyndt ≤ 30 dage før indskrivningsbesøg.
Signeret ICF
Ekskluderingskriterier:
Tidligere bruger af Opsumit defineret som patient, der påbegyndte behandling >30 dage før tilmelding.
Patienter, der er indskrevet i eventuelle igangværende kliniske forsøg
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Opsumit (macitentan)
10 mg tabletter
|
10 mg tabletter
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
At estimere incidensrater for specificerede resultater.
Tidsramme: 1 år
|
Leverprøveabnormaliteter/Forekomst af leverbivirkninger (HAE'er)/Forekomst af enhver anden AE’er/ Seponering af Opsumit og årsag til at stoppe behandlingen/ Hospitalsindlæggelse og død.
|
1 år
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
At beskrive demografiske og kliniske karakteristika for patienter behandlet med Opsumit ved indskrivning og i observationsperioden.
Tidsramme: 1 år
|
1 år
|
Andre resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
At beskrive PAH-behandlingsmønstre ved indskrivning og i observationsperiode.
Tidsramme: 1 år
|
1 år
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Studiestol: V McLaughlin, MD, Chair of the OPUS scientific committee (OSC)
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
30. april 2014
Primær færdiggørelse (Faktiske)
24. april 2020
Studieafslutning (Faktiske)
24. april 2020
Datoer for studieregistrering
Først indsendt
29. april 2014
Først indsendt, der opfyldte QC-kriterier
29. april 2014
Først opslået (Anslået)
30. april 2014
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
30. marts 2025
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
28. marts 2025
Sidst verificeret
1. marts 2025
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- AC-055-503
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Pulmonal arteriel hypertension
-
Universitaire Ziekenhuizen KU LeuvenUniversity of Pittsburgh; Sheba Medical Center; Mount Sinai Hospital, Canada og andre samarbejdspartnereRekrutteringTwin Reversal Arterial Perfusion SyndromeSpanien, Tyskland, Israel, Belgien, Holland, Canada, Forenede Stater, Østrig, Frankrig, Italien, Det Forenede Kongerige
-
Nanfang Hospital, Southern Medical UniversityRekrutteringBevacizumab | Hepatecellular carcinoma | QL1706 | RALOX-HAIC (Hepatic Arterial Infusion Chemoterapi med Raltitrexed og Oxaliplatin) | Type VP3/4 Portalvene Tumor Trombose | Iparomlimab og Tuvonralimab-injektionKina
-
VIVUS LLCIkke rekrutterer endnuPulmonal arteriel hypertension | Pulmonal arteriel hypertension (PAH) (WHO Group 1 PH) | Pulmonal arteriel hypertension (PAH) | Pulmonal arteriel hypertension WHO gruppe I | Pulmonal arteriel hypertension PAH
-
Inhibikase TherapeuticsIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)
-
Philipps University MarburgMSD Sharp & Dohme GmbH, GermanyIkke rekrutterer endnu
-
BayerAfsluttet
-
National Taiwan University Hospital Hsin-Chu BranchRekrutteringHypertension, essentiel | Hypertension, maskeretTaiwan
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc...Ikke rekrutterer endnuPulmonal hypertension | Pulmonal arteriel hypertension (PAH)Forenede Stater
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of MichiganIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Forenede Stater
-
University of Sao Paulo General HospitalRekrutteringPulmonal arteriel hypertension (PAH)Brasilien
Kliniske forsøg med Opsumit (macitentan)
-
University of California, Los AngelesTrukket tilbageAfvisning af lungetransplantationForenede Stater
-
Boston UniversityActelionAfsluttetSeglcellesygdom | Pulmonal hypertensionForenede Stater
-
ActelionEPS Corporation; Imepro Inc.; General Laboratory, BML, Inc.; Mitsubishi Logistics...AfsluttetKronisk tromboembolisk pulmonal hypertension (CTEPH)Japan
-
Dr Sudarshan RajagopalJanssen Pharmaceutica N.V., BelgiumRekruttering
-
ActelionAfsluttet
-
ActelionAfsluttet
-
University of California, Los AngelesAmerican Heart Association; Janssen, LPAfsluttet
-
Franz Rischard, DOUniversity of Pittsburgh; National Jewish HealthTrukket tilbagePulmonal hypertension | Interstitiel lungesygdom | SklerodermiForenede Stater
-
Janssen Pharmaceutical K.K.AfsluttetPulmonal arteriel hypertensionJapan